OVID
NASDAQ · Biotechnology
Ovid Therapeutics Inc
$2.44
+0.01 (+0.41%)
Open$2.46
Previous Close$2.43
Day High$2.48
Day Low$2.41
52W High$3.11
52W Low$1.18
Volume—
Avg Volume2.15M
Market Cap460.90M
P/E Ratio—
EPS$-0.25
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+1,582.0% upside
Current
$2.44
$2.44
Target
$41.04
$41.04
$30.97
$41.04 avg
$66.83
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.59M | 10.99M | 31.11M |
| Net Income | -44,616,919 | -23,747,842 | -8,350,078 |
| Profit Margin | -240.1% | -228.1% | -26.8% |
| EBITDA | -108,028,858 | -60,693,958 | -13,566,183 |
| Free Cash Flow | — | — | -8,976,737 |
| Rev Growth | +69.1% | +69.1% | +19.5% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |